03/10/2012

Pharmaceutical Company Jobs Boost

Dublin, Minister for Jobs,Enterprise and Innovation, Richard Bruton TD, has announced that Aspen, one of the leading generic pharmaceutical companies in the world, is to create 44 new high quality jobs.

The company first established an operation in Ireland in 2010 which has now become Aspen’s EuropeanMarketing and Supply Chain Headquarters; in addition the company is now establishing a global regulatory, pharmacovigilance, quality assurance and supply projectscentre of excellence in Citywest. The announcement is supported by the Irish Government through IDA Ireland.

In addition to being one of the largest generic global pharmaceutical companiesAspenis also the largest producer of anti-retroviral (HIV) drugs in South Africa. The new jobs will bring Aspen’s total workforce in Irelandto 58.

Making the announcement, Minister for Jobs,Enterpriseand Innovation, Richard Bruton TD said: "Pharmaceuticals is a major sector of strength for Ireland, with nine out of the top ten global companies located here. However a key part of the Government’s plan for jobs and growth is targeting the areas of growth within what is a changing sector – in particular, generics. Today’s announcement thatAspen, one of the world’s leading generic pharmaecutical companies is expanding its operations here is very welcome news. I am determined to ensure that we build on this to target further generics investments to create the jobs and growth we need."

Welcoming the announcement, Stephen Saad, group Chief Executive of Aspen said: "I am delighted to see the continued growth of Aspen here inIreland.Ireland provides for us a workforce with the specialised skills we require and a strong regulatory and business environment. I would like to thank the Irish Government and IDA Ireland for their support and look forward to the future development of Aspen in Ireland."

Commenting on the announcement, Barry O’Leary, CEO of IDA Ireland said: "Aspen’s decision to locate this operation here adds to Ireland’s cluster of life science companies and will add to our reputation as a leading centre for this sector. A key member of this cluster in Ireland is GlaxoSmithKline which owns a 20% share of Aspen. Ireland offers South Africa’s largest pharmaceutical company a strategic location from which to support its ongoing expansion and grow its sales across Europe. I wish Aspen every success with this expansion and look forward to continue to work closely with the company as it further embeds its operations here."

(GK)

Related Northern Ireland Business News Stories
Click here for the latest headlines.

11 November 2010
Firms Win InterTradeIreland Competition
Two NI firms have excelled in what is the largest business competition on the island of Ireland - Seedcorn 2010. Run by InterTradeIreland, the organisation that supports small and medium-sized businesses across Ireland for better North/South trade and business development, it offers a total prize fund of €280,000.
22 March 2024
Northern Ireland's Best Areas For Broadband Revealed
West Belfast has been named the Northern Ireland area with the best broadband, according to a new study. The experts at Getac – Rugged Computing Solutions analysed data from Ofcom Connected Nations 2023 to reveal the spots with the best broadband.
17 December 2018
InterTradeIreland Announce Funding Advisory Workshops
InterTradeIreland have announced a series of free funding advisory workshops for small and medium-sized enterprises.
25 October 2018
Techstart Academy Announce Product Management Workshop
The Techstart Academy has announced an event in Belfast on 22 November, which aims to "bring to life" the fundamentals of product management and best practices to drive product success.
09 July 2009
Arntz Belting Heads For Trouble
The future for a struggling Pennyburn fan belt factory, which currently employs around 110 people, is looking bleak. The manufacturing plant, Arntz Belting Company, went to a three-day week in December and also sought 28 redundancies in March. However, the global recession has led to the firm's parent company looking at further cuts.